A pilot safety and tolerability open-label study of interferon beta-1b in combination with tacrolimus in patients suffering from multiple sclerosis who have failed treatment with approved disease modifying agents.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Interferon beta-1b (Primary) ; Tacrolimus (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 21 Nov 2006 Interim results have been reported.
- 15 Oct 2006 New trial record.